WNTRESEARCH AB
6Patents
6Active
6Granted
47Portfolio score
Filing activity: Nov 28, 2007 → Mar 15, 2023 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8497352B2 | Use of Wnt5-α peptide derivates for the treatment of melanoma and gastric cancer | Human Necessities | 3 | Active |
| US11912791B2 | Solution phase routes for Wnt hexapeptides | Emerging Cross-Sectional Technologies | 1 | Active |
| US9278119B2 | Treatment of prostate cancer and a method for determining the prognosis for prostate cancer patients | Physics | 1 | Active |
| US8674060B2 | Peptide ligand to impair cancer cell migration | Human Necessities | 0 | Active |
| US11970551B2 | Solution phase routes for WNT hexapeptides | Emerging Cross-Sectional Technologies | 0 | Active |
| US12129277B2 | Linear solution phase routes for WNT hexapeptides | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.